• All sections
  • C - Chemistry; metallurgy
  • C07D - Heterocyclic compounds
  • C07D 401/04 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring- member bond

Patent holdings for IPC class C07D 401/04

Total number of patents in this class: 11562

10-year publication summary

945
839
907
882
901
881
877
827
810
205
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Principal owners for this class

Owner
All patents
This class
Bristol-myers Squibb Company
5080
282
Novartis AG
11238
218
Celgene Corporation
1412
177
F. Hoffmann-La Roche AG
7958
155
Merck Patent GmbH
5909
155
Janssen Pharmaceutica N.V.
3839
148
Boehringer Ingelheim International GmbH
4629
147
Vertex Pharmaceuticals Incorporated
1581
121
Takeda Pharmaceutical Company Limited
2961
119
Merck Sharp & Dohme LLC
3689
113
Hoffmann-La Roche Inc.
3060
108
AstraZeneca AB
3042
108
BASF SE
19740
102
Syngenta Participations AG
4970
100
Bayer AG
3045
98
FMC Corporation
910
98
Pfizer Inc.
3322
93
Amgen Inc.
3779
86
Sumitomo Chemical Company, Limited
8808
84
Gilead Sciences, Inc.
1879
79
Other owners 8971